論文・診療ガイドライン

診療ガイドライン

心筋症診療ガイドライン(2018年改訂版)
(日本循環器学会/日本心不全学会合同ガイドライン)
日本循環器学会 循環器病ガイドラインシリーズからご参照ください。

雑誌

  • JCS/JHFS 2025 Guideline on Diagnosis and Treatment of Heart Failure.
    Kitai T, Kohsaka S, Kato T, Kato E, Sato K, Teramoto K, Yaku H, Akiyama E, Ando M, Izumi C, Ide T, Iwasaki YK, Ohno Y, Okumura T, Ozasa N, Kaji S, Kashimura T, Kitaoka H, Kinugasa Y, Kinugawa S, Toda K, Nagai T, Nakamura M, Hikoso S, Minamisawa M, Wakasa S, Anchi Y, Oishi S, Okada A, Obokata M, Kagiyama N, Kato NP, Kohno T, Sato T, Shiraishi Y, Tamaki Y, Tamura Y, Nagao K, Nagatomo Y, Nakamura N, Nochioka K, Nomura A, Nomura S, Horiuchi Y, Mizuno A, Murai R, Inomata T, Kuwahara K, Sakata Y, Tsutsui H, Kinugawa K; Japanese Circulation Society and the Japanese Heart Failure Society Joint Working Group.
    Circ J. 2025 (Mar) : Online ahead of print.
  • Validation of Guideline Recommendation on Sudden Cardiac Death Prevention in Hypertrophic Cardiomyopathy.
    Amano M, Kitaoka H, Yoshikawa Y, Sakata Y, Dohi K, Tokita Y, Kato T, Matsushima S, Kitai T, Okada A, Furukawa Y, Tamura T, Hayashida A, Abe H, Ando K, Yuda S, Inoko M, Kadota K, Abe Y, Iwakura K, Kitamura T, Masuda J, Ohara T, Omura T, Tanigawa T, Nakamura K, Nishimura K, Izumi C; REVEAL-HCM Investigators.
    JACC Heart Fail. 2025 (Mar): Online ahead of print.
  • Electron microscopic findings predict clinical outcomes in patients with non-ischaemic cardiomyopathy.
    Higuchi R, Konishi S, Ohtani T, Sera F, Chimura M, Kanzaki M, Katsimichas T, Seo M, Watanabe T, Okumura T, Murohara T, Takahama H, Okada A, Izumi C, Hatano M, Komuro I, Ikeda Y, Asano Y, Ishibashi-Ueda H, Sakata Y.
    ESC Heart Fail. 2025 (Mar): Online ahead of print.
  • Ratio of pulmonary artery diameter to ascending aortic diameter and its association with right ventricular failure after left ventricular assist device implantation.
    Chimura M, Ohtani T, Sera F, Nakamoto K, Akazawa Y, Kajitani K, Higuchi R, Kagiya T, Sakata Y.
    Int J Cardiol. Vol.418 January 2025: p.132596.
  • Four cardiomyopathy patients with a heterozygous DSG2 p.Arg119Ter variant.
    Sumida T, Ogawa S, Higo S, Kuramoto Y, Eto R, Ikeda Y, Sun C, Li J, Liu L, Tabata T, Asano Y, Shiba M, Akazawa Y, Nakamura D, Oka T, Ohtani T, Sakata Y.
    Hum Genome Var. 2024 Vol.11, no. 1: pp.1- 9.
  • Sarcomere gene variants did not improve cardiac function in pediatric patients with dilated cardiomyopathy from Japanese cohorts.
    Hirono K, Hata Y, Ichimata S, Nishida N, Imamura T, Asano Y, Kuramoto Y, Tsuboi K, Takarada S, Okabe M, Nakaoka H, Ibuki K, Ozawa S, Muneuchi J, Yasuda K, Urayama K, Oka H, Miyamoto T, Baba K, Kato A, Saiki H, Kuwabara N, Harada M, Baba S, Morikawa M, Iwasaki H, Hirata Y, Ito Y, Sakaguchi H, Urata S, Toda K, Kittaka E, Okada S, Hasebe Y, Hoshino S, Fujii T, Mitsushita N, Nii M, Ogino K, Fujino M, Yoshida Y, Fukuda Y, Iwashima S, Takigiku K, Sakata Y, Inuzuka R, Maeda J, Hayabuchi Y, Fujioka T, Namiki H, Fujita S, Nishida K, Kuraoka A, Kan N, Kido S, Watanabe K, Ichida F.
    Sci Rep. 2024 Dec 16;14(1): p.30469.
  • Phase 3 Open-Label Study Evaluating the Efficacy and Safety of Mavacamten in Japanese Adults With Obstructive Hypertrophic Cardiomyopathy - The HORIZON-HCM Study.
    Kitaoka H, Ieda M, Ebato M, Kozuma K, Takayama M, Tanno K, Komiyama N, Sakata Y, Maekawa Y, Minami Y, Ogimoto A, Takaya T, Yasuda S, Amiya E, Furukawa Y, Watanabe T, Hiraya D, Miyagoshi H, Kinoshita G, Reedy A, Hegde SM, Florea V, Izumi C.
    Circ J. 2024 Dec 25;89(1): pp. 130-138.
  • 指定難病最前線 肥大型心筋症
    美馬響, 大谷朋仁, 坂田泰史.
    新薬と臨牀、74(1)、pp.32-38、2025年1月.
  • コンソーシアム研究から政策研究への応用展開
    大谷朋仁, 坂田泰史.
    心臓、57(1)、pp.34-36、2025年1月.
  • Increasing survivors of anthracycline-related cardiomyopathy with breast cancer in trastuzumab era: thirty-one-year trends in a Japanese Community.
    Watanabe M, Fujiki S, Okura Y, Toshikawa C, Ikarashi M, Kanbayashi C, Kaneko K, Kikuchi A, Sakata E, Tsuchida K, Ozaki K, Moro K, Kubota N, Kashimura T, Moriyama M, Sato N, Tanabe N, Koyama Y, Wakai T, Saijo Y, Inomata T.
    Breast Cancer. 2024 31 (6): pp.1080-1091.
  • Association Between Clonal Hematopoiesis and Left Ventricular Reverse Remodeling in Nonischemic Dilated Cardiomyopathy.
    Inoue S, Ko T, Shindo A, Nomura S, Yamada T, Jimba T, Dai Z, Nakao H, Suzuki A, Kashimura T, Iwahana T, Goto K, Matsushima S, Ishida J, Amiya E, Zhang B, Kubota M, Sawami K, Heryed T, Yamada S, Katoh M, Katagiri M, Ito M, Nayakama Y, Fujiu K, Hatano M, Takeda N, Takimoto E, Akazawa H, Morita H, Yamaguchi J, Inomata T, Kobayashi Y, Minamino T, Tsutsui H, Kurokawa M, Aiba A, Aburatani H, Komuro I.
    JACC Basic Transl Sci. 2024 9 (8): pp. 956-967.
  • JCS/JHFS 2025 Guideline on Diagnosis and Treatment of Heart Failure.
    Kitai T, Kohsaka S, Kato T, Kato E, Sato K, Teramoto K, Yaku H, Akiyama E, Ando M, Izumi C, Ide T, Iwasaki YK, Ohno Y, Okumura T, Ozasa N, Kaji S, Kashimura T, Kitaoka H, Kinugasa Y, Kinugawa S, Toda K, Nagai T, Nakamura M, Hikoso S, Minamisawa M, Wakasa S, Anchi Y, Oishi S, Okada A, Obokata M, Kagiyama N, Kato NP, Kohno T, Sato T, Shiraishi Y, Tamaki Y, Tamura Y, Nagao K, Nagatomo Y, Nakamura N, Nochioka K, Nomura A, Nomura S, Horiuchi Y, Mizuno A, Murai R, Inomata T, Kuwahara K, Sakata Y, Tsutsui H, Kinugawa K; Japanese Circulation Society and the Japanese Heart Failure Society Joint Working Group.
    J Card Fail. 2025 (Mar)S1071-9164(25) 00100-9: Online ahead of print.
  • 2023 Update of the Japanese Heart Failure Society Scientific Statement on BNP and NT-proBNP levels in Heart Failure Practice.
    Minamisawa M, Anzai T, Inomata T, Kinugawa K, Sakata Y, Sato N, Tsutsui H, Yamamoto K, Yoshimura M, Saito Y, Kuwahara K.
    J Card Fail. 2025 (Mar)S1071-9164(25) 00139-3: Online ahead of print.
  • JCS/JCC/JSPCCS 2024 Guideline on Genetic Testing and Counseling in Cardiovascular Disease.
    Imai Y, Kusano K, Aiba T, Ako J, Asano Y, Harada-Shiba M, Kataoka M, Kosho T, Kubo T, Matsumura T, Minamino T, Minatoya K, Morita H, Nishigaki M, Nomura S, Ogino H, Ohno S, Takamura M, Tanaka T, Tsujita K, Uchida T, Yamagishi H, Ebana Y, Fujita K, Ida K, Inoue S, Ito K, Kuramoto Y, Maeda J, Matsunaga K, Neki R, Sugiura K, Tada H, Tsuji A, Yamada T, Yamaguchi T, Yamamoto E, Kimura A, Kuwahara K, Maemura K, Minamino T, Morisaki H, Tokunaga K; Japanese Circulation Society; Japanese College of Cardiology; Japanese Society of Pediatric Cardiology; Cardiac Surgery Joint Working Group.
    Circ J. 2024 88(12): pp.2022-2099.
  • Ability of dynamic chest radiography to identify left ventricular systolic dysfunction in heart failure.
    Hiraiwa H, Nagai S, Ito R, Kondo K, Kazama S, Kondo T, Adachi S, Furusawa K, Tanaka A, Morimoto R, Okumura T, Murohara T.
    Int J Cardiovasc Imaging. 2025 (Mar) 41(3): pp. 507-521.
  • Characteristics, Treatment, and Prognosis in Octogenarian and Older Patients With Acute Heart Failure in Japan - Prospective Observational Study on Acute Pharmacotherapy and Prognosis in Management of Acute Heart Failure (POPEYE-AHF Registry).
    Kuwayama T, Okumura T, Kondo T, Oishi H, Kimura Y, Kazama S, Araki T, Hiraiwa H, Morimoto R, Kanashiro M, Asano H, Kawaguchi K, Yoshida Y, Tanaka N, Morishima I, Murohara T.
    Circ J. 2024 89(1): pp.83-92.
  • Validation of Guideline Recommendation on Sudden Cardiac Death Prevention in Hypertrophic Cardiomyopathy.
    Amano M, Kitaoka H, Yoshikawa Y, Sakata Y, Dohi K, Tokita Y, Kato T, Matsushima S, Kitai T, Okada A, Furukawa Y, Tamura T, Hayashida A, Abe H, Ando K, Yuda S, Inoko M, Kadota K, Abe Y, Iwakura K, Kitamura T, Masuda J, Ohara T, Omura T, Tanigawa T, Nakamura K, Nishimura K, Izumi C; REVEAL-HCM Investigators.
    JACC Heart Fail. 2025 (Mar) S2213-1779(25)00083-6: Online ahead of print.
  • 周産期心筋症
    神谷千津子
    臨床雑誌内科、134(2)、pp. 257-259、2024年.
  • 周産期心筋症
    神谷千津子
    臨床婦人科産科、78(4)、pp. 239-244、2024年.
  • Decreased plasma cell-free mitochondrial DNA may be a new biomarker of tachycardia-induced cardiomyopathy in patients with atrial fibrillation.
    Miyamoto S, Tokuyama T, NakanoY.et al.
    Int J Cardiol. 2024 417: p.132579.
  • Clinical Features of Tachycardia-induced Cardiomyopathy in Patients with Atrial Fibrillation.
    Uotani Y, Sasaki N, Nakano Y et al.
    Intern Med. 2024 63(18): pp. 2509-2517.
  • Nationwide Survey on Transitional Care for Patients With Childhood-Onset Cardiomyopathy in Japan.
    Soma K, Ochiai R, Tsutsui H, Takeda N, Yao A.
    Circ Rep. 2024 6(6): pp. 209-216.
  • Influenza Vaccination and Cardiovascular Events in Japanese Patients With Heart Failure - Findings From the PARALLEL-HF Trial.
    Tsutsui H, Momomura SI, Saito Y, Ito H, Yamamoto K, Sakata Y, Ohishi T, Ito C; PARALLEL-HF Investigators.
    Circ Rep. 2024 6(9): pp. 366-371.
  • Management and outcomes of heart failure hospitalization among older adults in the United States and Japan.
    Bates BA, Enzan N, Tohyama T, Gandhi P, Matsushima S, Tsutsui H, Setoguchi S, Ide T.
    ESC Heart Fail. 2024 11(5): pp. 3395-3405.

書籍

  • 「野生型ATTRアミロイド―シス」猪又孝元.
    『アミロイドーシス診療ガイドライン2025』、pp.65-108、2024年.
  • 「心臓サルコイドーシス」猪又孝元.
    『今日の治療指針2025』、pp.415-416、2025年1月.
  • 「急性心筋炎」猪又孝元.
    『第9版今日の診断指針』、pp.801-803、2025年2月.
  • 「心臓病理が映し出すリバースリモデリング未来予想図」奥村貴裕.
    『Heart View』、pp.999-1003、2024年.
  • 「周産期心筋症」神谷千津子.
    『妊娠期別産科救急ナビゲーション』、pp.188-193、2025年1月.